Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 362

1.

What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial.

Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Spellmann I, Musil R, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug 28. doi: 10.1007/s00406-019-01055-4. [Epub ahead of print]

PMID:
31463563
2.

Strong primary care and patients' survival.

Wensing M, Szecsenyi J, Kaufmann-Kolle P, Laux G.

Sci Rep. 2019 Jul 26;9(1):10859. doi: 10.1038/s41598-019-47344-9.

3.

[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 Sep;90(9):958-960. doi: 10.1007/s00115-019-0766-7. German. No abstract available.

PMID:
31309271
4.

Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.

Schennach R, Obermeier M, Spellmann I, Seemüller F, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, Adli M, Zeiler J, Bender W, Kronmüller KT, Ising M, Brieger P, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.

Schizophr Res. 2019 Jul;209:185-192. doi: 10.1016/j.schres.2019.04.022. Epub 2019 May 25.

PMID:
31138482
5.

The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?

Rozanski V, Laux G, Schwarz J.

Clin Neuropharmacol. 2019 May/Jun;42(3):77-79. doi: 10.1097/WNF.0000000000000332.

PMID:
30829882
6.
7.

[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].

Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C.

Nervenarzt. 2019 May;90(5):463-471. doi: 10.1007/s00115-018-0643-9. Review. German. Erratum in: Nervenarzt. 2019 Jul 15;:.

PMID:
30446893
8.

Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.

Schennach R, Riedel M, Spellmann I, Musil R, Obermeier M, Jäger M, Bottlender R, Schmauss M, Laux G, Möller HJ.

Pharmacopsychiatry. 2019 Jul;52(4):180-185. doi: 10.1055/a-0669-9461. Epub 2018 Sep 20.

PMID:
30235496
9.

Patients with somatoform disorders: More frequent attendance and higher utilization in primary Out-of-Hours care?

Leutgeb R, Berger S, Szecsenyi J, Laux G.

PLoS One. 2018 Aug 30;13(8):e0202546. doi: 10.1371/journal.pone.0202546. eCollection 2018.

10.

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction.

Schwill S, Krug K, Peters-Klimm F, van Lieshout J, Laux G, Szecsenyi J, Wensing M.

BMC Fam Pract. 2018 Jul 18;19(1):115. doi: 10.1186/s12875-018-0796-4.

11.

Anticholinergic and sedative medications and the risk of vertigo or dizziness in the German primary care setting-A matched case-control study from the CONTENT registry.

Phillips A, Strobl R, Grill E, Laux G.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):912-920. doi: 10.1002/pds.4575. Epub 2018 Jun 13.

PMID:
29896933
12.

Effects of a program to strengthen general practice care on hospitalisation rates: a comparative observational study.

Wensing M, Kolle PK, Szecsenyi J, Stock C, Laux G.

Scand J Prim Health Care. 2018 Jun;36(2):109-114. doi: 10.1080/02813432.2018.1459429. Epub 2018 Apr 6.

13.

Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Musil R, Seemüller F, Meyer S, Spellmann I, Adli M, Bauer M, Kronmüller KT, Brieger P, Laux G, Bender W, Heuser I, Fisher R, Gaebel W, Schennach R, Möller HJ, Riedel M.

Int J Methods Psychiatr Res. 2018 Mar;27(1). doi: 10.1002/mpr.1569. Epub 2017 Jun 14.

PMID:
29498147
14.

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.

Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C.

World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi: 10.1080/15622975.2018.1439595. Epub 2018 Mar 1. Review.

PMID:
29493375
15.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. No abstract available.

PMID:
29390205
16.

A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).

Ricken R, Wiethoff K, Reinhold T, Stamm TJ, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Laux G, Hauth I, Möller HJ, Heinz A, Bauer M, Adli M.

J Affect Disord. 2018 Mar 1;228:173-177. doi: 10.1016/j.jad.2017.11.051. Epub 2017 Nov 13.

PMID:
29253683
17.

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P.

Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Review. Erratum in: Pharmacopsychiatry. 2018 Jan;51(1-02):e1.

18.

Editorial to Driving Ability and Psychotropic Drugs.

Laux G, Bauer M.

Pharmacopsychiatry. 2017 Sep;50(5):169-171. doi: 10.1055/s-0043-118483. Epub 2017 Sep 12. German. No abstract available.

PMID:
28898894
19.

Driving Under the Influence of Antidepressants: A Systematic Review and Update of the Evidence of Experimental and Controlled Clinical Studies.

Brunnauer A, Laux G.

Pharmacopsychiatry. 2017 Sep;50(5):173-181. doi: 10.1055/s-0043-113572. Epub 2017 Jul 17. Review.

PMID:
28718182
20.

[Prescription of Benzodiazepines and Z-Drugs by German General Practitioners: A Cross-Sectional Study].

Moßhammer D, Haumann H, Muche R, Scheub D, Joos S, Laux G.

Gesundheitswesen. 2018 Oct;80(10):916-922. doi: 10.1055/s-0043-104694. Epub 2017 Jul 3. German.

PMID:
28672410
21.

How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.

Adli M, Wiethoff K, Baghai TC, Fisher R, Seemüller F, Laakmann G, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Kronmüller KT, Smolka MN, Schlattmann P, Berger M, Ricken R, Stamm TJ, Heinz A, Bauer M.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):721-730. doi: 10.1093/ijnp/pyx043.

22.

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Spellmann I, Musil R, Möller HJ, Riedel M.

Pharmacopsychiatry. 2017 Jul;50(4):136-144. doi: 10.1055/s-0043-106436. Epub 2017 May 15.

PMID:
28505669
23.

Erratum to: Out of hours care in Germany - High utilization by adult patients with minor ailments?

Leutgeb R, Engeser P, Berger S, Szecsenyi J, Laux G.

BMC Fam Pract. 2017 May 12;18(1):64. doi: 10.1186/s12875-017-0632-2. No abstract available.

24.

[Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].

Schmidt C, Bätzing-Feigenbaum J, Bestmann A, Brinks R, Dreß J, Goffrier B, Hagen B, Laux G, Pollmanns J, Schröder H, Stahl T, Baumert J, Du Y, Gabrys L, Heidemann C, Paprott R, Scheidt-Nave C, Teti A, Ziese T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):656-661. doi: 10.1007/s00103-017-2552-7. Review. German.

PMID:
28466131
25.

Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: An analysis of routine data.

Kraus EM, Pelzl S, Szecsenyi J, Laux G.

PLoS One. 2017 Mar 28;12(3):e0174584. doi: 10.1371/journal.pone.0174584. eCollection 2017.

26.

Out of hours care in Germany - High utilization by adult patients with minor ailments?

Leutgeb R, Engeser P, Berger S, Szecsenyi J, Laux G.

BMC Fam Pract. 2017 Mar 21;18(1):42. doi: 10.1186/s12875-017-0609-1. Erratum in: BMC Fam Pract. 2017 May 12;18(1):64.

27.

Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice.

Laux G, Barthel B, Hajak G, Lemke M, Volz HP.

Adv Ther. 2017 Apr;34(4):895-914. doi: 10.1007/s12325-017-0485-z. Epub 2017 Feb 18.

PMID:
28214983
28.

Evaluation of a program to strengthen general practice care for patients with chronic disease in Germany.

Wensing M, Szecsenyi J, Stock C, Kaufmann Kolle P, Laux G.

BMC Health Serv Res. 2017 Jan 21;17(1):62. doi: 10.1186/s12913-017-2000-2.

29.

Update Psychopharmacotherapy.

Laux G.

Med Monatsschr Pharm. 2017 Jan;40(1):4-14. Review. English, German.

PMID:
29952523
30.

Multiple-file vs. single-file endodontics in dental practice: a study in routine care.

Bartols A, Laux G, Walther W.

PeerJ. 2016 Dec 7;4:e2765. eCollection 2016.

31.

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.

Spellmann I, Schennach R, Seemüller F, Meyer S, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Bauer M, Adli M, Zeiler J, Bender W, Kronmüller KT, Ising M, Brieger P, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):303-313. doi: 10.1007/s00406-016-0741-2. Epub 2016 Oct 26.

PMID:
27785605
33.

Differences between Practice Patterns of Conventional and Naturopathic GPs in Germany.

Laux G, Musselmann B, Kiel M, Szecsenyi J, Joos S.

PLoS One. 2016 Oct 3;11(10):e0163519. doi: 10.1371/journal.pone.0163519. eCollection 2016.

34.

Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.

Seemüller F, Obermeier M, Schennach R, Bauer M, Adli M, Brieger P, Laux G, Riedel M, Falkai P, Möller HJ.

BMC Psychiatry. 2016 May 20;16:153. doi: 10.1186/s12888-016-0851-4.

35.

[Care of patients with cancer pain in general practices in Germany].

Engeser P, Kuate Fokan E, Laux G, Szecsenyi J, Krug K, Leutgeb R.

Schmerz. 2016 Jun;30(3):266-72. doi: 10.1007/s00482-016-0110-0. German.

PMID:
27059043
36.

[Assessment of ability to drive in patients with MCI and dementia].

Haussmann R, Wagner T, Müller D, Bauer M, Laux G, Donix M.

Nervenarzt. 2017 Mar;88(3):247-253. doi: 10.1007/s00115-016-0097-x. Review. German.

PMID:
27056190
37.

[Driving ability in mental illness].

Laux G.

MMW Fortschr Med. 2015 Nov 12;157 Spec No 2:50-3; quiz 54. Review. German. No abstract available.

PMID:
26953477
38.

A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe.

Baumann P, Spies M, Möller HJ, Kasper S, Bitter I, Laux G.

World J Biol Psychiatry. 2017 Feb;18(1):29-38. doi: 10.3109/15622975.2016.1149219. Epub 2016 Apr 6. Review.

39.

Driving skills in unmedicated first- and recurrent-episode schizophrenic patients.

Segmiller FM, Buschert V, Laux G, Nedopil N, Palm U, Furjanic K, Zwanzger P, Brunnauer A.

Eur Arch Psychiatry Clin Neurosci. 2017 Feb;267(1):83-88. doi: 10.1007/s00406-015-0647-4. Epub 2015 Oct 25.

PMID:
26499939
40.

Mobility behaviour and driving status of patients with mental disorders - an exploratory study.

Brunnauer A, Buschert V, Segmiller F, Zwick S, Bufler J, Schmauss M, Messer T, Möller HJ, Frommberger U, Bartl H, Steinberg R, Laux G.

Int J Psychiatry Clin Pract. 2016;20(1):40-6. doi: 10.3109/13651501.2015.1089293. Epub 2015 Oct 7.

PMID:
26442635
41.

Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.

Schennach R, Möller HJ, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Musil R, Spellmann I, Riedel M.

Int J Methods Psychiatr Res. 2016 Mar;25(1):3-11. doi: 10.1002/mpr.1476. Epub 2015 Jul 14.

PMID:
26178421
42.

[GP-centered health care in Baden-Württemberg, Germany: Results of a quantitative and qualitative evaluation].

Laux G, Szecsenyi J, Mergenthal K, Beyer M, Gerlach F, Stock C, Uhlmann L, Miksch A, Bauer E, Kaufmann-Kolle P, Steeb V, Lübeck R, Karimova K, Güthlin C, Götz K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Apr;58(4-5):398-407. doi: 10.1007/s00103-015-2122-9. German.

PMID:
25665890
43.

Driving performance and psychomotor function in depressed patients treated with agomelatine or venlafaxine.

Brunnauer A, Buschert V, Fric M, Distler G, Sander K, Segmiller F, Zwanzger P, Laux G.

Pharmacopsychiatry. 2015 Mar;48(2):65-71. doi: 10.1055/s-0034-1398509. Epub 2015 Feb 2.

PMID:
25642916
44.

[Reality of treatment in psychotherapy: Results of a survey of German psychiatric hospitals].

Laux G, Sander K, Artmann S, Dreher J, Lenz J, Hauth I.

Nervenarzt. 2015 May;86(5):579-87. doi: 10.1007/s00115-014-4193-5. German.

PMID:
25620735
45.

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Eur Psychiatry. 2015 Jan;30(1):43-50. doi: 10.1016/j.eurpsy.2014.11.001. Epub 2014 Dec 22.

PMID:
25541347
46.

Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach.

Stock C, Uhlmann L, Hoffmeister M, Laux G, Kieser M, Brenner H.

Gastrointest Endosc. 2015 Mar;81(3):646-654.e1. doi: 10.1016/j.gie.2014.09.049. Epub 2014 Dec 16.

PMID:
25523387
47.

Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders.

Köhler S, Wiethoff K, Ricken R, Stamm T, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Zeiler J, Heinz A, Bauer M, Adli M.

J Affect Disord. 2015 Mar 1;173:126-33. doi: 10.1016/j.jad.2014.10.059. Epub 2014 Nov 10.

PMID:
25462406
48.

[Characteristics of Health-Care Provision for Patients in Out-of-Hours Care and Regular Care].

Leutgeb R, Szecsenyi J, Kuehlein T, Laux G.

Gesundheitswesen. 2015 Oct;77(10):757-60. doi: 10.1055/s-0034-1390434. Epub 2014 Nov 5. German.

PMID:
25372654
49.

Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.

Dörr O, Liebetrau C, Möllmann H, Mahfoud F, Ewen S, Gaede L, Troidl C, Hoffmann J, Busch N, Laux G, Wiebe J, Bauer T, Hamm C, Nef H.

Clin Res Cardiol. 2015 Feb;104(2):175-84. doi: 10.1007/s00392-014-0773-4. Epub 2014 Oct 18.

PMID:
25326158
50.

What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):107-16. doi: 10.1007/s00406-014-0528-2. Epub 2014 Sep 27.

PMID:
25261210

Supplemental Content

Support Center